Glaxosmithkline Pharmaceuticals

GLAXO

₹ 3,246.52

- ₹ 1.44

0.04%

Healthcare

₹ 0.00

(%)1D

Updated: 14 Jun 2025, 06:01:30 pm IST

Stock Score

Open Price

₹ 3,249.31

Prev. Close

₹ 3,247.96

₹ 3,219.06

Day Low

₹ 3,285.23

Day High

₹ 1,905.55

52 Week Low

₹ 3,470.09

52 Week High

Quick Bite

Price To Earnings Ratio 59.29	Sector PE 29.91
PB Ratio 27.97	Sector PB 8.19
EPS 54.76	Dividend Yield 1.88
Today's Volume 12.090 K	5 Day Avg. Volume 98.877 K
PEG Ratio 1.04	Market Cap. ₹ 58,250.00 Cr.

About Glaxosmithkline Pharmaceuticals

GlaxoSmithKline Pharmaceuticals Limited is an India-based global healthcare company. The Company is engaged in the business of manufacturing, distributing and trading in pharmaceuticals. The Company has three product areas: vaccines, specialty and general medicine. Its general medicines business has a portfolio of medicines in anti-infectives, pain, vitamins medicine, nutritional, hormones, dermatologicals, respiratory and vaccines for adults and children. The Company's general medicine brands include Augmentin, Calpol, Ceftum, Eltroxin, CCM, Neosporin, Betnovate, Tenovate, T-bact and Physiogel. The Company's vaccine brands include Shingrix Herpes Zoster Vaccine, Infanrix Hexa, Synflorix, Boostrix, Havrix, Menveo, Fluarix Tetra and Varilrix. Its specialty medicine brands include Nucala, Seretide, and Trelegy Ellipta. Trelegy Ellipta, single inhaler triple therapy (SITT) for chronic obstructive pulmonary disease (COPD) patients. The Subsidiary of the Company is Biddle Sawyer Limited.

Glaxosmithkline Pharmaceuticals Share Price

GlaxoSmithKline Pharmaceuticals Limited is a pharmaceutical company. The company's field of activity is the production, distribution and trade of medicines. It produces drugs used in the pharmaceutical industry, such as antibiotics, endocrine products, essential vitamins; opium derivatives; sulfa drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and plant alkaloids and chemically pure sugar. It offers a variety of prescription drugs, vaccines and consumer health products. Its drug portfolio includes Adartrel, Bactroban, Combodart and Duodart. Its vaccine portfolio includes Ambirix, Cervarix, Fendrix and Havrix. The company's products include betamethasone, clavulanate potassium with amoxicillin, and pneumococcal polysaccharide and conjugate vaccine. Its oral care products include Sensodyne, parodontax and Polident. Its manufacturing unit is located in Nashik.

Glaxosmithkline Pharmaceuticals FAQs

How to Buy Glaxosmithkline Pharmaceuticals Share?

To purchase Glaxosmithkline Pharmaceuticals shares, you can open a Demat & Trading account through a broker or financial institution. Once your account is set up and funded, search for Glaxosmithkline Pharmaceuticals (ticker symbol: GLAXO) on the trading platform provided by your broker and purchase the shares.

What's Glaxosmithkline Pharmaceuticals share price today?

The stock price of Glaxosmithkline Pharmaceuticals as of 17 Jun 2025 is ₹3,246.52

What is the Market Cap of Glaxosmithkline Pharmaceuticals?

Market capitalisation represents the total market value of a company's outstanding shares. As of 17 Jun 2025, Glaxosmithkline Pharmaceuticals (ticker symbol: GLAXO) has a market capitalisation of approximately ₹5,82,50,00,00,000.00

What is the PE and PB ratio of Glaxosmithkline Pharmaceuticals?

Glaxosmithkline Pharmaceuticals Ltd's price-to-book ratio as of 17 Jun 2025 is 27.97, reflecting the market's valuation compared to its asset value. As of 17 Jun 2025, the trailing twelve months P/E (price-to-earnings) ratio is 59.29, indicating the market values the company at around ₹59.29 for every ₹1 of earnings

What is the 52 Week High and Low of Glaxosmithkline Pharmaceuticals Share?

Glaxosmithkline Pharmaceuticals Ltd (GLAXO) hit its 52-week high at ₹3,470.09, and its 52-week low at ₹1,905.55.

Begin your investment journey today

View All Global Indices